Antimicrobial stewardship in urology

International Journal of Urology

Volumn 21, Issue 7, 2014, Pages 628-629

  Deguchi, Takashi ^a   Matsumoto, Tetsuro ^b  

^a GIFU UNIVERSITY   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CYSTOSCOPY; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE BIOPSY; UROLOGIC SURGERY; UROLOGY; INFECTION CONTROL; MICROBIOLOGY; URINARY TRACT INFECTIONS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; INFECTION CONTROL; URINARY TRACT INFECTIONS;

EID: 84903647277     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/iju.12432     Document Type: Article

References (10)

1. Hayami H, Takahashi S, Ishikawa K etal. Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus. J. Infect. Chemother. 2013; 19: 393-403.
2. Muratani T, Matsumoto T. Urinary tract infection caused by fluoroquinolone- and cephem-resistant Enterobacteriaceae. Int. J. Antimicrob. Agents 2006; 28 (Suppl 1): S10-13.
3. Ito M, Yasuda M, Yokoi S etal. Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones. Antimicrob. Agents Chemother. 2004; 48: 3185-3187.
4. Matsumoto T, Kiyota H, Matsukawa M etal. Japanese guidelines for prevention of perioperative infections in urological field. Int. J. Urol. 2007; 14: 890-909.
5. Togo Y, Taoka R, Yamamoto S etal. A questionnaire survey of antimicrobial prophylaxis to prevent perioperative infection in urological field in Japan. Nihon Hinyokika Gakkai Zasshi 2013; 104: 579-588.
6. Çek M, Tandoǧdu Z, Naber K etal. Antibiotic prophylaxis in urology departments, 2005-2010. Eur. Urol. 2013; 63: 386-394.
7. Dellit TH, Owens RC, McGowan JE Jr etal. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin. Infect. Dis. 2007; 44: 159-177.
8. Shlaes DM, Gerding DN, John JF Jr etal. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin. Infect. Dis. 1997; 25: 58-99.
9. Society for Healthcare Epidemiology of America; Infectious Diseases Society of America; Pediatric Infectious Diseases Society. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect. Control Hosp. Epidemiol. 2012; 33: 322-327.
10. Wagenlehner FM, Bartoletti R, Cek M etal. Antibiotic stewardship: a call for action by the urologic community. Eur. Urol. 2013; 64: 358-360.